ORGO Covered Call Strategy
ORGO (Organogenesis Holdings Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio, Organogenesis offers several distinct products. These include Affinity and Novachor, both amniotic membrane dressings designed to preserve vital cells, growth factors, and ECM proteins found in natural tissue. Apligraf is a bioengineered living cell therapy that releases a range of healing cytokines and growth factors, while Dermagraft is another bioengineered solution that generates human collagen, ECM, proteins, and cytokines. NuShield provides a wound covering incorporating both amnion and chorion membranes to maintain a spongy intermediate layer. PuraPly acts as an antimicrobial barrier, allowing for flexibility and effective fluid drainage.
ORGO (Organogenesis Holdings Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $232.9M, a beta of 1.33 versus the broader market, a 52-week range of 1.54-7.077, average daily share volume of 1.1M, a public-listing history dating back to 2017, approximately 854 full-time employees. These structural characteristics shape how ORGO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.33 indicates ORGO has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a covered call on ORGO?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
ORGO snapshot
As of August 14, 2026, spot at $1.79, ATM IV 22.60%, IV rank 4.39%, expected move 6.48%. The covered call on ORGO below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on ORGO specifically: ORGO IV at 22.60% is on the cheap side of its 1-year range, which means a premium-selling ORGO covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 6.48% (roughly $0.12 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ORGO expiries trade a higher absolute premium for lower per-day decay. Position sizing on ORGO should anchor to the underlying notional of $1.79 per share and to the trader's directional view on ORGO stock.
ORGO covered call setup
The ORGO covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ORGO at $1.79 on that close, the first option leg uses a $1.88 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ORGO chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ORGO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $1.79 | long |
| Sell 1 | Call | $1.88 | N/A |
ORGO covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
ORGO covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on ORGO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on ORGO
Covered calls on ORGO are an income strategy run on existing ORGO stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
ORGO thesis for this covered call
The market-implied 1-standard-deviation range for ORGO extends from approximately $1.67 on the downside to $1.91 on the upside. A ORGO covered call collects premium on an existing long ORGO position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether ORGO will breach that level within the expiration window. Current ORGO IV rank near 4.39% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ORGO at 22.60%. As a Healthcare name, ORGO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ORGO-specific events.
ORGO covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ORGO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ORGO alongside the broader basket even when ORGO-specific fundamentals are unchanged. Short-premium structures like a covered call on ORGO carry tail risk when realized volatility exceeds the implied move; review historical ORGO earnings reactions and macro stress periods before sizing. Always rebuild the position from current ORGO chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on ORGO?
- A covered call on ORGO is the covered call strategy applied to ORGO (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With ORGO stock at $1.79 on the most recent close, the strikes shown on this page are snapped to the nearest listed ORGO chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ORGO covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the ORGO covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 22.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ORGO covered call?
- The breakeven for the ORGO covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ORGO market-implied 1-standard-deviation expected move in the same options snapshot is approximately 6.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on ORGO?
- Covered calls on ORGO are an income strategy run on existing ORGO stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current ORGO implied volatility affect this covered call?
- ORGO ATM IV is at 22.60% with IV rank near 4.39%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.